AC
CVS icon

ASB Consultores’s CVS Health CVS Stock Holding History

ASB Consultores’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-4,960
Closed -$396K – 227
2024
Q1 		$396K Buy
+4,960
New +$379K 0.1% 148
2023
Q3 		– Sell
-2,932
Closed -$203K – 151
2023
Q2 		$203K Sell
2,932
-1,670
-36% -$119K 0.1% 174
2023
Q1 		$342K Sell
4,602
-843
-15% -$70.7K 0.14% 116
2022
Q4 		$507K Buy
5,445
+29
+0.5% +$2.8K 0.21% 63
2022
Q3 		$517K Buy
5,416
+270
+5% +$26.7K 0.24% 52
2022
Q2 		$477K Buy
5,146
+1,021
+25% +$99.6K 0.21% 56
2022
Q1 		$417K Buy
4,125
+704
+21% +$74K 0.18% 103
2021
Q4 		$353K Buy
+3,421
New +$316K 0.17% 129

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

ASB Consultores's CVS Position: Q2 2024 in Review

ASB Consultores sold out of CVS Health (CVS) in Q2 2024, closing a stake of 4,960 shares — an estimated $396K sold.

ASB Consultores first reported a position in CVS in Q4 2021 and held it in 8 quarters. The position peaked at $517K in Q3 2022. 1,910 funds tracked by Wall St. Rank hold CVS as of Q2 2024.

  • ASB Consultores reported no remaining CVS Health position as of Q2 2024 after selling out during the quarter.
  • ASB Consultores sold 4,960 CVS Health shares in Q2 2024, an estimated $396K.
  • ASB Consultores first reported a position in CVS Health in Q4 2021 and held it in 8 quarters.
  • ASB Consultores's CVS Health position peaked at $517K in Q3 2022.
  • 1,910 funds tracked by Wall St. Rank held CVS Health as of Q2 2024.

Based on ASB Consultores's 13F filing for Q2 2024, filed 12 Aug 2024.